Structure of compound 12

selective GluN2B negative allosteric mod.

active in brain, proj. oral dose of 120 mg

from cell-based HTS and opt.

J. Med. Chem., Jul. 31, 2020

Janssen R&D, San Diego, CA

“compound 12” is a selective negative allosteric modulator of the GluN2B subunit of NDMA receptors intended for treatment of mood disorders. In this program, poor solubility and permeability were a…


 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.